Table of Contents
ISRN Pulmonology
Volume 2013 (2013), Article ID 409862, 6 pages
http://dx.doi.org/10.1155/2013/409862
Clinical Study

Lung Cancer Diagnosed More Than Five Years after the Development of Polymyositis/Dermatomyositis

Department of Pulmonary Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan

Received 29 March 2013; Accepted 8 May 2013

Academic Editors: C. Flores and A. S. Melani

Copyright © 2013 Ken Uchibori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bohan and J. B. Peter, “Polymyositis and dermatomyositis—I,” New England Journal of Medicine, vol. 292, no. 7, pp. 344–347, 1975. View at Google Scholar · View at Scopus
  2. A. Bohan and J. B. Peter, “Polymyositis and dermatomyositis (Second of two parts),” New England Journal of Medicine, vol. 292, no. 8, pp. 403–407, 1975. View at Google Scholar · View at Scopus
  3. P. Ungprasert, N. Leeaphorn, N. Hosiriluck et al., “Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in Asian population,” ISRN Rheumatology, vol. 2013, Article ID 509354, 7 pages, 2013. View at Publisher · View at Google Scholar
  4. G. Sterz, “Polymyositis,” Berlin Klinische Wochenschrift, vol. 53, article 489, 1916. View at Google Scholar
  5. B. B. Antiochos, L. A. Brown, Z. Li, T. D. Tosteson, R. L. Wortmann, and W. F. C. Rigby, “Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA,” Journal of Rheumatology, vol. 36, no. 12, pp. 2704–2710, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Yazici and L. J. Kagen, “The association of malignancy with myositis,” Current Opinion in Rheumatology, vol. 12, no. 6, pp. 498–500, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Stockton, V. R. Doherty, and D. H. Brewster, “Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study,” British Journal of Cancer, vol. 85, no. 1, pp. 41–45, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Buchbinder, A. Forbes, S. Hall, X. Dennett, and G. Giles, “Incidence of malignant disease in biopsy-proven inflammatory myopathy: a population-based cohort study,” Annals of Internal Medicine, vol. 134, no. 12, pp. 1087–1095, 2001. View at Google Scholar · View at Scopus
  9. C. L. Hill, Y. Zhang, B. Sigurgeirsson et al., “Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study,” The Lancet, vol. 357, no. 9250, pp. 96–100, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Sigurgeirsson, B. Lindelof, O. Edhag, and E. Allander, “Risk of cancer in patients with dermatomyositis or polymyositis—a population-based study,” New England Journal of Medicine, vol. 326, no. 6, pp. 363–367, 1992. View at Google Scholar · View at Scopus
  11. Y. Saito, M. Odaka, S. Sato et al., “Clinicopathological study of resected and autopsied cases of lung cancer associated with dermatomyositis,” Japanese Journal of Lung Cancer, vol. 44, no. 7, pp. 763–766, 2004. View at Google Scholar · View at Scopus
  12. M. A. Verducci, G. D. Malkasian Jr., S. J. Friedman, and R. K. Winkelmann, “Gynecologic carcinoma associated with dermatomyositis-polymyositis,” Obstetrics and Gynecology, vol. 64, no. 5, pp. 695–698, 1984. View at Google Scholar · View at Scopus
  13. L. Casciola-Rosen, K. Nagaraju, P. Plotz et al., “Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy,” Journal of Experimental Medicine, vol. 201, no. 4, pp. 591–601, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Fiorentino and L. Casciola-Rosen, “Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer-myositis connection,” Arthritis and Rheumatism, vol. 64, no. 2, pp. 346–349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. B. E. Barnes and B. Mawr, “Dermatomyositis and malignancy: a review of the literature,” Annals of Internal Medicine, vol. 84, no. 1, pp. 68–76, 1976. View at Google Scholar · View at Scopus
  16. U.S. Department of Health and Human Services, “The Health Consequences of Smoking: A Report of the Surgeon General,” Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004, http://www.cdc.gov/tobacco/data_statistics/sgr/2004/index.htm.
  17. M. Parkin, J. E. Tyczynski, P. Boffetta, J. Samet, P. Shields, and N. Caporaso, “Lung cancer epidemiology and etiology,” in Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, W. D. Travis, E. Brambilla, H. K. Müller-Hermelink, and C. C. Harris, Eds., pp. 12–15, WHO Press, Geneva, Switzerland, 3rd edition, 2004, http://www.tcshelp.com. View at Google Scholar
  18. R. Hubbard, A. Venn, S. Lewis, and J. Britton, “Lung cancer and cryptogenic fibrosing alveolitis: a population-based cohort study,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 1, pp. 5–8, 2000. View at Google Scholar · View at Scopus
  19. K. Archotogeorgis, P. Steirolpoulos, A. Tzouvelekis, E. Nena, and D. Bouros, “Lung cancer and interstitial lung diseases: a systematic review,” Pulmonary Medicine, vol. 2012, Article ID 315918, 11 pages, 2012. View at Publisher · View at Google Scholar
  20. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans IARC Monographs, Volume 100, A Review of Human Carcinogens, Part A: Pharmaceuticals. International Agency for Research on Cancer, Lyon, France, 2008, http://monographs.iarc.fr/ENG/Monographs/vol100A/index.php.